查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1146329

医疗用品市场 - 增长、趋势、COVID-19 的影响、预测 (2022-2027)

Medical Supplies Market - Growth, Trends, and Forecasts (2022 - 2027)
出版日期: | 出版商: Mordor Intelligence | 英文 110 Pages | 商品交期: 2-3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

医疗用品市场预计在 2022-2027 年的预测期内復合年增长率为 3.4%。

COVID-19 大流行对市场产生了各种影响。当前，各国继续面临大流行病的巨大威胁。 COVID-19 造成的供应链中断导致全球关键医疗用品短缺。因此，许多国家已采取明确措施进口商品以缓解短缺。

据 FDA 称，2022 年 7 月，由于 COVID-19 大流行，州联邦政府实施了多项限制措施。 《联邦食品、药品和化妆品法》（FD&C 法）第 506J 节反映了食品药品监督管理局 (FDA) 确定在 COVID-19 公共卫生紧急事件期间供不应求的设备类别。随着它的发展而更新。供不应求的主要医疗用品是“透析相关产品”、“个人防护设备”、“检测用品和设备”以及“呼吸相关产品”。这种短缺导致对医疗用品的高需求，对市场做出了重大贡献。

根据 2022 年 1 月发布的 Kauffman Hall National Hospital Bulletin，从 2019 年到 2021 年，医疗用品短缺将使每位患者的住院费用增加 20.6%。最近由 Delta 和 Omicron 变体引起的激增进一步增加了医院的压力。采用次优替代品是医院供应炼网络中的一个主要问题。大流行后，公司可以考虑采用增材製造等现代生产技术来减少对产品的依赖。在大流行之前，准时制 (JIT) 政策是製造业的常态。在准时制政策下，供应链代理很少在供应炼网络内维护成品和原材料的库存。但是，洗手液和卫生纸等部分产品的需求激增。因此，企业面临着原材料和产能的严重短缺。因此，上述 COVID-19 响应表明，虽然 JIT 可能会降低库存成本，但在危机情况下并不合适。因此，在后疫情时代，将有必要将采购策略从全球转向本地。供应链经理采取措施改变全球采购方式，并在生产地点附近寻找和推广当地质量相同的原材料来源。因此，不仅是全球玩家，本土玩家之间的竞争也越来越激烈。因此，预计在大流行后期间该地区对医疗用品的需求将会增加。

慢性病是最常见的健康状况，需要花费大量金钱。慢性病包括癌症、糖尿病、高血压、中风、心脏病、呼吸系统疾病、关节炎和肥胖症，这些疾病可能导致住院、长期残疾、生活质量低下，甚至死亡。根据世界卫生组织 (WHO) 的数据，到 2021 年全球将有大约 4.22 亿人患上糖尿病，每年有 150 万人直接死于糖尿病。在过去的几十年里，糖尿病的患病率和患病率都在稳步上升。根据 2021 年 8 月发布的《第一次全球高血压患病率、检测、治疗和控制趋势综合分析》，在过去 30 年中，患有高血压的 30 至 79 岁成年人占 6 亿。据说从 50亿至 12.8 亿。由于慢性病、生活方式相关疾病和伤害的增加，对医疗用品的需求非常高。对市场供应的高需求正在推动市场增长。

因此，上述因素共同归因于预测期内研究的市场增长。然而，严格的监管框架预计将阻碍预测期内的市场增长。

主要市场趋势

在预测期内，导管部分有望实现高速增长

导管是一种细而柔韧的管子，可让您从体内註入和抽出液体。导管有五种类型：心血管导管、静脉导管、导尿管、特种导管和神经血管导管。导管被发现占有最大份额，这可能归因于心血管疾病发病率的上升和全球导管相关手术数量的增加。根据 2020 年美国人口普查局的一份报告，预计从 2025 年到 2060 年，所有四种心血管危险因素都会增加，其中糖尿病增加最快（增加 39.3% 至 55 亿），其次是血脂异常（增加 27.6% 至 1.26 亿），高血压（上升 25.1% 至 1.62 亿）和肥胖症（上升 18.3% 至 1.26 亿）。我来了。根据美国疾病控制与预防中心（CDC）的数据，2020 年心脏病将在美国夺去约 697,000 人的生命，其中冠心病最为常见，全美有 382,□□820 人死亡，约 805,000 人心脏病发作每年。据说它正在造成随着与膀胱相关的慢性疾病、心血管疾病和其他疾病患病率的增加，这些疾病是推动增长的主要因素。此外，由于疾病及其治疗方法的流行，患者对微创手术的需求不断增加，这进一步推动了这一领域的增长。

北美有望主导医疗用品市场

由于产品创新的高年度投资和现有技术的不断改进等因素，预计北美将主导市场。北美最大的市场是美国。

美国医疗用品行业是医疗保健行业的重要组成部分。该市场与Johnson & Johnson Services, Inc、Abbott和Baxter International Inc.等医疗用品市场的主要参与者竞争激烈。根据美国癌症协会 2021 年的数据，约有 190 万例新发癌症被诊断出来，其中包括 268,490 例前列腺癌、287,850 例浸润性乳腺癌、236,740 例肺癌和 106,180 例结直肠癌。预计这些趋势将推动未来的市场增长。

因此，由于上述因素，预计北美地区的市场增长。

竞争格局

由于多家公司在全球和区域运营，医疗用品市场在本质上是分散的。竞争格局包括 Medtronic plc、Cardinal Health、Becton、Dickinson and Company、Johnson & Johnson Services, Inc、B. Braun Melsungen AG、Boston Scientific Corporation、Thermo Fisher Scientific, Inc、Baxter、3M Company、Smith & Nephew 它包括分析多家具有市场份额的知名国际和本地公司，例如：

其他福利。

  • Excel 格式的市场预测 (ME) 表
  • 三个月的分析师支持

内容

第一章介绍

  • 研究假设和市场定义
  • 调查范围

第二章研究方法论

第 3 章执行摘要

第四章市场动态

  • 市场概览
  • 市场驱动因素
    • 慢性病患病率增加
    • 医疗事故数量增加
    • 医院和外科中心的手术数量和 ICU 入院人数增加
    • 政府补贴医疗费用的努力
  • 市场製约因素
    • 产品召回
    • 国家级医疗器械法规
  • 波特的五力分析
    • 新进入者的威胁
    • 买方/消费者议价能力
    • 供应商的议价能力
    • 替代品的威胁
    • 竞争公司之间的敌对关係

第 5 章市场细分（基于价值的市场规模：百万美元）

  • 按产品类型
    • 诊断耗材
    • 输液和注射用品
    • 插管和通气用品
    • 消毒剂
    • 个人防护装备
    • 灭菌耗材
    • 伤口护理耗材
    • 透析相关耗材
    • 辐射相关消耗品
    • 导管
    • 其他医疗器械
  • 通过申请
    • 泌尿科
    • 伤口敷料
    • 放射科
    • 呼吸科
    • 感染控制
    • 心脏病学
    • 体外诊断
    • 其他用途
  • 最终用户
    • 医院
    • 诊所和诊所
    • 其他最终用户
  • 按地区
    • 北美
      • 美国
      • 加拿大
      • 墨西哥
    • 欧洲
      • 德国
      • 英国
      • 法国
      • 意大利
      • 西班牙
      • 其他欧洲地区
    • 亚太地区
      • 中国
      • 日本
      • 印度
      • 澳大利亚
      • 韩国
      • 其他亚太地区
    • 中东和非洲
      • 海湾合作委员会
      • 南非
      • 其他中东地区
    • 南美洲地区
      • 巴西
      • 阿根廷
      • 其他南美洲

第六章竞争格局

  • 公司简介
    • Medtronic plc
    • Cardinal Health
    • Becton, Dickinson and Company
    • Johnson & Johnson Services, Inc.
    • B. Braun Melsungen AG
    • Boston Scientific Corporation
    • Thermo Fisher Scientific, Inc.
    • Baxter
    • 3M Company
    • Smith & Nephew
    • Abbott
    • Convatec Inc.
    • Cook Medical
    • Stryker
    • Hamilton Medical

第七章市场机会与未来趋势

简介目录
Product Code: 91905

The Medical Supplies Market is expected to register a CAGR of 3.4% over the forecast period, 2022-2027. The COVID-19 pandemic had a mixed impact on the market. Currently, countries continue to face the huge threat of the pandemic. The supply chain disruption caused due to COVID-19 led to shortages of critical medical supplies worldwide. Therefore, many countries have taken definite measures to ease the shortages by importing supplies.

According to 'FDA,' July 2022, due to the COVID-19 pandemic, several restrictive measures have been implemented by the State federation's governments. Section 506J of the Federal Food, Drug, and Cosmetic Act (FD&C Act) reflects the categories of devices that Food and Drug Administration (FDA) has determined to be in shortage and maintained and updated as the COVID-19 public health emergency evolves. The major medical supplies in shortage are Dialysis-Related Products, Personal Protective Equipment, Testing Supplies and Equipment and Ventilation-Related Products. The shortage led to high demand for medical supplies, significantly contributing to the market.

According to "Kaufman Hall National Hospital Flash Report," published in January 2022, there is an increase of 20.6% in Hospital expenses per patient from 2019 to 2021 caused due to shortage of medical supplies. The most recent surges triggered by the delta and omicron variants have added even more pressure to hospitals. Adoption of suboptimal substitutes is a major issue in supply chain networks in hospitals. Following the pandemic, businesses may consider reducing dependence by implementing modern production techniques like additive manufacturing. Just in Time (JIT) policy was the standard in manufacturing companies prior to the pandemic. Supply chain agents maintain little finished goods or raw material inventory in the supply chain network under a just-in-time policy. But several of the products, including hand sanitizers and toilet paper, saw a sharp rise in demand. Therefore, there was a severe shortage of both raw materials and production capacity for the enterprises. As a result, the above response to COVID-19 implies that, while JIT may provide lower inventory costs, it is not appropriate during times of crisis. Hence, it will be necessary to change the sourcing strategy from global to local in the post-pandemic era. Supply chain managers take steps to change their global sourcing and work to find and promote local sources that offer comparable quality raw materials close to their production facilities. Hence there is high competition among the global as well as local players. Therefore, the post-pandemic period is expected to see an increase in the demand for medical supplies in the region.

Chronic diseases are the most prevalent health condition that involves significant expenditure. Chronic diseases include cancer, diabetes, hypertension, stroke, heart disease, respiratory diseases, arthritis, and obesity, which can lead to hospitalization, long-term disability, reduced quality of life, and even death. According to the World Health Organization (WHO), by 2022 approximately 422 million worldwide have diabetes in 2021, and 1.5 million deaths are directly attributed to diabetes each year. Both the number of cases and the prevalence of diabetes have been steadily increasing over the past few decades. According to the 'first comprehensive global analysis of trends in hypertension prevalence, detection, treatment and control' published in August 2021, the number of adults aged 30-79 years with hypertension has increased from 650 million to 1.28 billion in the last 30 years. The increasing prevalence of chronic and lifestyle diseases, and the high volume of cases of injuries places a great demand for medical supplies products. The high demand for market supplies drives the growth of the market.

Therefore, the factors mentioned above are attributed collectively to the studied market growth over the forecast period. However, a stringent regulatory framework is expected to hinder market growth over the forecast period.

Key Market Trends

Catheter Segment is Expected to Witness High Growth Over the Forecast Period

A catheter is a thin, flexible tube that can put fluids into your body or take them out. There are five types of catheters: cardiovascular catheters, intravenous catheters, urological catheters, specialty catheters and neurovascular catheters. Catheters are found to hold the largest share which can be attributed to the rising incidence of cardiovascular disease and the increasing volume of catheter related surgeries, across the globe. According to the U.S. Census Bureau report, published in 2020, all four cardiovascular risk factors are expected to increase from 2025 to 2060, with the largest percentage increase in diabetes (39.3% increase to 55 million persons), followed by dyslipidemia (27.6% increase to 126 million persons), hypertension (25.1% increase to 162 million persons) and obesity (18.3% increase to 126 million persons). According to Centers for Disease Control and Prevention (CDC) in 2020, about 697,000 people in the United States died from heart disease out of which coronary heart disease is the most common type of heart disease, killing 382,820 people and about 805,000 people in the United States have a heart attack every year. With increase in prevalence of chronic diseases associated with urinary bladder, cardiovascular disease, and others are the major factors that drive the growth. In addition, the increase in demand for minimal invasive surgeries among patients owing to the increase disease prevalence and its treatment further fuels the segment growth.

North America is Expected to Dominate the Medical Supplies Market

North America is expected to dominate the market owing to factors such as higher investment of yearly revenues in product innovation and constant improvement of existing technologies. The United States is the largest market in North America.

The US medical supply sector is an important part of the healthcare industry. The market has a very competitive landscape, with leading medical supply market players, such as Johnson & Johnson, Abbott, and Baxter International. According to the American Cancer Society 2021, about 1.9 million new cancer cases were diagnosed, including 268,490 cases of prostate cancer, 287,850 cases of invasive breast cancer, 236,740 cases of lung cancer, and 106,180 cases of colorectal cancer. These trends are likely to boost the growth of the market in the future.

Therefore, owing to the aforesaid factors the growth of the market studied is anticipated in the North America Region.

Competitive Landscape

The Medical Supplies Market is fragmented in nature due to the presence of several companies operating globally as well as regionally. The competitive landscape includes an analysis of a few international as well as local companies which hold market shares and are well known. include Medtronic plc, Cardinal Health, Becton, Dickinson and Company, Johnson & Johnson Services, Inc., B. Braun Melsungen AG, Boston Scientific Corporation, Thermo Fisher Scientific, Inc., Baxter, 3M Company, and Smith & Nephew, among others.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Chronic Disease Prevalence
    • 4.2.2 Rising Number of Medical Emergencies
    • 4.2.3 Increase Number of Surgical Procedure and ICU Admission in Hospital and Surgical Centers
    • 4.2.4 Government Initiative in Healthcare Funding
  • 4.3 Market Restraints
    • 4.3.1 Product Recalls
    • 4.3.2 Country-level Medical Device Regulation
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value - USD million)

  • 5.1 By Product Type
    • 5.1.1 Diagnostic Supplies
    • 5.1.2 Infusion & Injectable Supplies
    • 5.1.3 Intubation & Ventilation Supplies
    • 5.1.4 Disinfectants
    • 5.1.5 Personal Protective Equipment
    • 5.1.6 Sterilization Consumables
    • 5.1.7 Wound Care Consumables
    • 5.1.8 Dialysis Consumables
    • 5.1.9 Radiology Consumables
    • 5.1.10 Catheters
    • 5.1.11 Other Medical Supplies
  • 5.2 By Application
    • 5.2.1 Urology
    • 5.2.2 Wound Care
    • 5.2.3 Radiology
    • 5.2.4 Respiratory
    • 5.2.5 Infection Control
    • 5.2.6 Cardiology
    • 5.2.7 IVD
    • 5.2.8 Other Applications
  • 5.3 By End-User
    • 5.3.1 Hospitals
    • 5.3.2 Clinics/Physician Offices
    • 5.3.3 Other End Users
  • 5.4 Geography
    • 5.4.1 North America
      • 5.4.1.1 United States
      • 5.4.1.2 Canada
      • 5.4.1.3 Mexico
    • 5.4.2 Europe
      • 5.4.2.1 Germany
      • 5.4.2.2 United Kingdom
      • 5.4.2.3 France
      • 5.4.2.4 Italy
      • 5.4.2.5 Spain
      • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia-Pacific
      • 5.4.3.1 China
      • 5.4.3.2 Japan
      • 5.4.3.3 India
      • 5.4.3.4 Australia
      • 5.4.3.5 South Korea
      • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle East and Africa
      • 5.4.4.1 GCC
      • 5.4.4.2 South Africa
      • 5.4.4.3 Rest of Middle East and Africa
    • 5.4.5 South America
      • 5.4.5.1 Brazil
      • 5.4.5.2 Argentina
      • 5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Medtronic plc
    • 6.1.2 Cardinal Health
    • 6.1.3 Becton, Dickinson and Company
    • 6.1.4 Johnson & Johnson Services, Inc.
    • 6.1.5 B. Braun Melsungen AG
    • 6.1.6 Boston Scientific Corporation
    • 6.1.7 Thermo Fisher Scientific, Inc.
    • 6.1.8 Baxter
    • 6.1.9 3M Company
    • 6.1.10 Smith & Nephew
    • 6.1.11 Abbott
    • 6.1.12 Convatec Inc.
    • 6.1.13 Cook Medical
    • 6.1.14 Stryker
    • 6.1.15 Hamilton Medical

7 MARKET OPPORTUNITIES AND FUTURE TRENDS